PPIDT00094

Drug Information
NameAnidulafungin
SequenceNot Available
DrugBank_IDDB00362
Typebiotech
IndicationFor use in the treatment of the following fungal infections: Candidemia and other forms of Candida infections (intra-abdominal abscess, and peritonitis), Aspergillus infections, and esophageal candidiasis. Also considered an alternative treatment for oropharyngeal canaidiasis.

Dosage Forms
Form Route Strength
Injection, powder, for solution Intravenous
100 mg
Injection, powder, for solution Parenteral
Injection, powder, for solution Parenteral
100 MG
Injection, powder, for solution
Injection, powder, for solution
100 MG
Injection, solution Intravenous
Injection, powder, for solution
50 mg
Injection, powder, for solution Intravenous; Parenteral
100 MG
Powder Intravenous
100 MG
Injection, powder, lyophilized, for solution Intravenous
100 mg
Solution Parenteral
122.000 mg
Injection, powder, lyophilized, for solution Intravenous
100 mg/30mL
Injection, powder, lyophilized, for solution Intravenous
50 mg/15mL
Kit Intravenous
100 mg/30mL
Kit Intravenous
50 mg/15mL
Powder Intravenous
100 mg/1vial
Powder, for solution Intravenous
100 mg / vial
Injection, powder, lyophilized, for solution Intravenous
Injection, powder, lyophilized, for solution Intravenous
100 mg/vial
Injection, solution, concentrate Intravenous
100 mg
Injection Parenteral
Solution Intravenous
100.000 mg
Injection, powder, lyophilized, for solution Intravenous
10000000 mg
Injection, solution Intravenous
100 mg
Target Information
Role Uniprot_ID Gene_Name Entity_Name Organism Actions Internal link
target A2QLK4 fksA 1,3-beta-glucan synthase component FKS1 Aspergillus niger (strain ATCC MYA-4892 / CBS 513.88 / FGSC A1513) inhibitor Link
target P40989 GSC2 1,3-beta-glucan synthase component GSC2 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) modulator Link